Alpha4 integrins as therapeutic targets in autoimmune disease

N Engl J Med. 2003 Jan 2;348(1):68-72. doi: 10.1056/NEJMe020157.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Humanized
  • Crohn Disease / drug therapy*
  • Humans
  • Immunoglobulins / metabolism
  • Integrin alpha4 / drug effects
  • Integrin alpha4 / immunology
  • Integrin alpha4 / metabolism
  • Integrin alpha4 / physiology*
  • Mucoproteins / metabolism
  • Multiple Sclerosis, Relapsing-Remitting / drug therapy*
  • Natalizumab

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Immunoglobulins
  • MADCAM1 protein, human
  • Mucoproteins
  • Natalizumab
  • Integrin alpha4